MISOPROSTOL (misoprostol) by Pfizer is clinical pharmacology pharmacokinetics: misoprostol is extensively absorbed, and undergoes rapid de-esterification to its free acid, which is responsible for its clinical activity and, unlike the parent compound, is detectable in plasma. Approved for prostaglandin e1 analog [epc]. First approved in 2022.
Drug data last refreshed 21h ago
CLINICAL PHARMACOLOGY Pharmacokinetics: Misoprostol is extensively absorbed, and undergoes rapid de-esterification to its free acid, which is responsible for its clinical activity and, unlike the parent compound, is detectable in plasma. The alpha side chain undergoes beta oxidation and the beta…
Worked on MISOPROSTOL at Pfizer? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Prostaglandin E1 Analog
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Comparison Between Vaginal Misoprostol Gel and Oral Misoprostol Solution in Induction of Labor
Cervical Ripening With Misoprostol vs Isosorbide Mononitrate ; A Parallel -Arm Randomized Controlled Trial
Comparison of Misoprostol Ripening Efficacy With Dilapan
REgistry of MisOprostol 200 µg Vaginal dElivery System
Buccal Versus Vaginal Misoprostol for Third Trimester Induction of Labor